Martingale Asset Management’s Acceleron Pharma Inc. XLRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-134,635
| Closed | -$23.2M | – | 921 |
|
|
2021
Q3 | $23.2M | Sell |
134,635
-25,713
| -16% | -$4.43M | 0.3% | 126 |
|
|
2021
Q2 | $20.1M | Buy |
160,348
+11,502
| +8% | +$1.44M | 0.23% | 146 |
|
|
2021
Q1 | $20.2M | Buy |
148,846
+42,095
| +39% | +$5.71M | 0.23% | 143 |
|
|
2020
Q4 | $13.7M | Buy |
106,751
+78,589
| +279% | +$10.1M | 0.16% | 156 |
|
|
2020
Q3 | $3.17M | Buy |
28,162
+3,651
| +15% | +$411K | 0.04% | 309 |
|
|
2020
Q2 | $2.34M | Buy |
24,511
+20,707
| +544% | +$1.97M | 0.03% | 477 |
|
|
2020
Q1 | $342K | Buy |
+3,804
| New | +$342K | ﹤0.01% | 871 |
|